Bibliografía
1. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999:79: 1431-1568.
2. Cheng YD, Al-Khoury L, Zivin JA. Neuroprotection for Ischemic Stroke: Two Decades of Successand Failure. The Journal of the American Society for Experimental NeuroTherapeutics 2004:1: 36-45.
3. DeBow SB, Clark DL, Maclellan CL, Colbourne F. Incomplete assessment of experimental cytoprotectants in rodent ischemia studies. Can J Neurol Sci 2003:30: 368-374.
4. Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 2003:26: 248-254.
5. Digicaylioglu M, Bichet S, Marti HH et al. Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc Natl Acad Sci U S A 1995:92: 3717-3720.
6. Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 2003:26: 248-254.
7. Buemi M, Cavallaro E, Floccari F et al. The pleiotropic effects of erythropoietin in the central nervous system. J Neuropathol Exp Neurol 2003:62: 228-236.
8. Buemi M, Grasso G, Corica F et al. In vivo evidence that erythropoietin has a neuroprotective effect during subarachnoid hemorrhage. Eur J Pharmacol 2000:392: 31-34.
9. Ehrenreich H, Hasselblatt M, Dembowski C et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 2002:8: 495-505.
10. Weiss MJ. New insights into erythropoietin and epoetin alfa: mechanisms of action, target tissues, and clinical applications. Oncologist 2003:8 Suppl 3:18-29.: 18-29.
11. Siren AL, Ehrenreich H. Erythropoietin--a novel concept for neuroprotection. Eur Arch Psychiatry Clin Neurosci 2001:251: 179-184.
12. Erbayraktar S, Grasso G, Sfacteria A et al. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci U S A 2003:100: 6741-6746.
13. Masuda S, Okano M, Yamagishi K, Nagao M, Ueda M, Sasaki R. A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. J Biol Chem 1994:269: 19488-19493.
14. Erbayraktar S, Grasso G, Sfacteria A et al. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci U S A 2003:100: 6741-6746.
15. Wang X, Zhu C, Wang X et al. The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin. J Neurochem 2004:91: 900-910.
16. Brines M, Ghezzi P, Keenan S et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. PNAS 2000:97: 10526-10531.
17. Grasso G, Sfacteria A, Cerami A, Brines M. Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go? Neuroscientist 2004:10: 93-98.
18. Wiessner C, Allegrini PR, Ekatodramis D, Jewell UR, Stallmach T, Gassmann M. Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin. J Cereb Blood Flow Metab 2001:21: 857-864.
19. Graff CL, Pollack GM. Nasal drug administration: potential for targeted central nervous system delivery. J Pharm Sci 2005:94: 1187-1195.
20. Graff CL, Pollack GM. Nasal drug administration: potential for targeted central nervous system delivery. J Pharm Sci 2005:94: 1187-1195.
21. Illum L. Nasal drug delivery--possibilities, problems and solutions. J Control Release 2003:87: 187-198.
22. Illum L. Nasal drug delivery--possibilities, problems and solutions. J Control Release 2003:87: 187-198.
23. Illum L. Nasal drug delivery: new developments and strategies. Drug Discov Today 2002:7: 1184-1189.
24. ILAR. Guide for the Care and Use of Laboratory Animals. Washington , D.C.: National Academy Press,1996.
25. Muñoz Cernuda, A., León Rodríguez, R., García Rodríguez, J. C., Nuñez Figueredo, Y., Pardo Ruiz, Z., García Salman, J. D., Sosa, I., Curbelo Rodríguez, D., Cruz Rodríguez, J., and Subiros Martínez, N. Formulaciones nasales de EPOhr con bajo contenido de ácido siálico para el tratamiento de enfermedades del Sistema Nervioso Central. (20050138). 22-7-0005. Cuba. Ref Type: Patent
26. Buterfield JD, Mcgraw CP. Efect of the DPPD (diphenyl-para-phenylendiamine) on stroke and cerebral edema in gerbils. Stroke 1978:9.
27. Lawner P, Laurent J, Simeone F, Fink E, Rubin E. Attenuation of ischemic brain edema by pentobarbital after carotid ligation in the gerbil. Stroke 1979:10: 644-647.
28. Colbourne F, Auer RN, Sutherland GR. Behavioral testing does not exacerbate ischemic CA1 damage in gerbils. Stroke 1998:29: 1967-1970.
29. Loskota WJ, Lomax P, Verity MA. A stereotaxic atlas of the Mongolian gerbil brain (Meriones unguiculatus). Los Angeles, California: Ann Arbor Science,1973.
30. Rasband, W. ImageJ. (1.34s). 2006. National Institutes of Health,USA. Ref Type: Computer Program
31. Traystman RJ. Animal Models of Focal and Global Cerebral Ischemia. ILAR Journal 2003:44: 85-95.
32. Castro Pacheco A, Niembro E, Pérez Pérez V, Hernández García J, Grijalba I. Comunicación arterial carotidobasilar en gerbos (Meriones unguiculatus). Rev Neurol 2001;32(3): 225-228. Revista de Neurología 2001:32: 225-228.
33. Hossmann K-A. Experimental models for the investigation of brain ischemia. Cardiovascular Research 1998:39: 106-120.
34. Somova LI, Gregory MA, Nxumalo EN. Mongolian gerbil (Meriones unguiculatus) as a model of cerebral infarction for testing new therapeutic agents. Methods Find Exp Clin Pharmacol 2000:22: 203-210.
35. Pelliccioli GP, Gambelunghe C, Ottaviano PF, Iannaccone S, Ambrosini MW. Variable response of the Mongolian gerbil to unilateral carotid occlusion: magnetic resonance imaging and neuropathological characterization. Ital J Neurol Sci 1995:16: 517-526.
36. Yu Y-P, Xu Q-Q, Zhang Q, Zhang W-P, Zhang L-H, Wei E-Q. Intranasal recombinant human erythropoietin protects rats against focal cerebral ischemia. Neuroscience Letters 2005:387: 5-10.
37. Sadamoto Y, Igase K, Sakanaka M et al. Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem Biophys Res Commun 1998:253: 26-32.
38. Catania MA, Marciano MC, Parisi A et al. Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils. Eur J Pharmacol 2002:437: 147-150.
39. Weber A, Maier RF, Hoffmann U et al. Erythropoietin improves synaptic transmission during and following ischemia in rat hippocampal slice cultures. Brain Res 2002:958: 305-311.
40. Marti HH. Erythropoietin and the hypoxic brain. J Exp Biol 2004:207: 3233-3242.
41. Payan HM, Conrad JR. Carotid ligation in gerbils. Influence of age, sex, and gonads. Stroke 1977:8: 194-196.
42. Castro-Pacheco A, Foyo-Niembro E, Perez-Perez V, Garcia-Hernandez J, Grijalva I. [Carotid-basilar artery communication in gerbils (Meriones unguiculatus)]. Rev Neurol 2001:32: 225-228.
43. Sosa, I., García Salman, J. D., Rodríguez, Y., Subiros, N., Rodríguez, K., and Thomas, A. Sensibilidad de los modelos de isquemia global y focal en el gerbil de Mongolia. http// www.Ilustrados.com:EyFpAVAlpCfBOoWnY . 2007. Ref Type: Electronic Citation
44. Graham D, Lantos P. Greenfield´s Neuropathology, Vol I, Sixth edn. New York:1997.
45. Siren AL, Fratelli M, Brines M et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A 2001:98: 4044-4049.
46. Shingo T, Sorokan ST, Shimazaki T, Weiss S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J Neurosci 2001:21: 9733-9743.
47. Marti HH, Bernaudin M, Petit E, Bauer C. Neuroprotection and angiogenesis: Dual role of erythropoietin in brain ischemia. News Physiological Sciences 2000:15: 225-229.
48. Wang L, Zhang Z, Wang Y, Zhang R, Chopp M. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 2004:35: 1732-1737.
49. Kirino T, Sano K. Fine structural nature of delayed neuronal death following ischemia in the gerbil hippocampus. Acta Neuropathol (Berl) 1984:62: 209-218.
50. Kirino T, Sano K. Selective vulnerability in the gerbil hippocampus following transient ischemia. Acta Neuropathol (Berl) 1984:62: 201-208.
51. Siren AL, Fratelli M, Brines M et al. Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A 2001:98: 4044-4049.
52. Grasso G. Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage. J Neurosurg Sci 2001:45: 7-14.
53. Villa P, Bigini P, Mennini T et al. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J Exp Med 2003:198: 971-975.
54. Sosa I, García Rodríguez JC, Santana J et al. Intranasal administration of recombinant human Erythropoietin exerts neuroprotective effects on post-ischemic brain injury in Mongolian gerbils. Pharmacologyonline 2006:1: 100-112.
55. Subiros Martínez, N., García Rodríguez, J. C., González Navarro, B., Sosa, I., and García Salman, J. D. Evaluación histológica del efecto de la Eritropoyetina vía intranasal, sobre la muerte neuronal retardada en gerbos sometidos a isquemia cerebral transitoria. Estudio preliminar. VII Congreso Virtual Hispanoamericano de Anatomía Patológica . 2005. Ref Type: Electronic Citation
|